Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Amdocs Limited (NASDAQ:DOX). In a filing disclosed on December 15th, the Representative disclosed that they had sold between $15,001 and $50,000 in Amdocs stock on November 12th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 11/26/2025.
- Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 11/26/2025.
- Purchased $1,001 – $15,000 in shares of First Watch Restaurant Group (NASDAQ:FWRG) on 11/26/2025.
- Purchased $1,001 – $15,000 in shares of TKO Group (NYSE:TKO) on 11/26/2025.
- Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 11/24/2025.
- Sold $1,001 – $15,000 in shares of Stifel Financial (NYSE:SF) on 11/24/2025.
- Purchased $1,001 – $15,000 in shares of Logan Energy (CVE:LGN) on 11/24/2025.
- Sold $1,001 – $15,000 in shares of Primoris Services (NASDAQ:PRIM) on 11/24/2025.
- Purchased $15,001 – $50,000 in shares of LandBridge (NYSE:LB) on 11/21/2025.
- Purchased $50,001 – $100,000 in shares of LandBridge (NYSE:LB) on 11/20/2025.
Amdocs Stock Performance
DOX traded up $0.62 during trading on Friday, hitting $80.48. The stock had a trading volume of 1,497,624 shares, compared to its average volume of 1,130,338. The company has a 50 day moving average price of $79.99 and a 200-day moving average price of $84.89. Amdocs Limited has a one year low of $74.32 and a one year high of $95.41. The firm has a market cap of $8.69 billion, a price-to-earnings ratio of 15.94, a P/E/G ratio of 1.35 and a beta of 0.43. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.17 and a quick ratio of 1.22.
Amdocs Dividend Announcement
Institutional Investors Weigh In On Amdocs
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Dakota Wealth Management acquired a new stake in Amdocs during the 2nd quarter valued at $458,000. JPMorgan Chase & Co. increased its stake in Amdocs by 13.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 266,124 shares of the technology company’s stock valued at $24,281,000 after buying an additional 31,827 shares during the period. Foster & Motley Inc. lifted its stake in shares of Amdocs by 21.0% in the second quarter. Foster & Motley Inc. now owns 45,764 shares of the technology company’s stock worth $4,176,000 after buying an additional 7,934 shares during the last quarter. Savant Capital LLC lifted its position in shares of Amdocs by 91.8% in the 2nd quarter. Savant Capital LLC now owns 8,243 shares of the technology company’s stock worth $752,000 after acquiring an additional 3,946 shares during the period. Finally, Acadian Asset Management LLC boosted its stake in shares of Amdocs by 36.2% in the 2nd quarter. Acadian Asset Management LLC now owns 684,218 shares of the technology company’s stock valued at $62,416,000 after purchasing an additional 181,719 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
DOX has been the subject of several recent research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Stifel Nicolaus cut their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Finally, Bank of America decreased their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $97.00.
View Our Latest Analysis on Amdocs
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- Short Selling – The Pros and Cons
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- Find and Profitably Trade Stocks at 52-Week Lows
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
- Stock Average Calculator
- MarketBeat Week in Review – 12/15 – 12/19
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
